Staffan Encrantz - Mar 10, 2025 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Signature
/s/ Jeremy Hayden, Attorney-in-Fact for Staffan Encrantz
Stock symbol
SGHT
Transactions as of
Mar 10, 2025
Transactions value $
$1,383,210
Form type
4
Date filed
3/13/2025, 07:22 PM
Previous filing
Nov 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGHT Common Stock Other $304K +120K +2.62% $2.53 4.69M Mar 10, 2025 See footnote F1, F2
transaction SGHT Common Stock Other $407K +150K +3.2% $2.71 4.84M Mar 11, 2025 See footnote F1, F3
transaction SGHT Common Stock Other $673K +243K +5.02% $2.77 5.09M Mar 12, 2025 See footnote F1, F4
holding SGHT Common Stock 632K Mar 10, 2025 See footnote F5
holding SGHT Common Stock 1.03M Mar 10, 2025 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the President and sole director of Allegro Investment Inc., which is the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund for purposes of Rule 13d-3 under the Securities Exchange Act of 1934 (the "Exchange Act"). However, the Reporting Person does not have any pecuniary interest in the shares held by Allegro Investment Fund and disclaims beneficial ownership with respect to all such shares. Accordingly, this report is being provided voluntarily by the Reporting Person for informational purposes only and shall not be deemed an admission that the Reporting Person is the beneficial owner of any such shares for purposes of Section 16 under the Exchange Act or for any other purpose.
F2 The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at per share prices ranging from $2.455 to $2.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at per share prices ranging from $2.465 to $2.875 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at per share prices ranging from $2.665 to $2.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F5 These shares of Common Stock are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust for purposes of Rule 13d-3 under the Exchange Act. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 under the Exchange Act or for any other purpose), except to the extent of his pecuniary interest therein, if any.
F6 Includes (i) 1,012,150 shares of Common Stock and (ii) 17,366 restricted stock units, which are subject to vesting as previously reported.